Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

NCT02399410 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: perioperative chemotherapy plus bevacizumab
PROCEDURE: cytoreductive surgery
DRUG: Intraperitoneal Oxaliplatin

Sponsor

University Hospital, Ghent